View Post

HRQoL effects of breast cancer prognosis, treatment predict mortality risk

In In The News by Barbara Jacoby

By: Hannah Kitt From: The health-related quality of life (HRQoL) of patients with ductal carcinoma in situ (DCIS) or invasive breast cancer is impaired by their prognosis and treatment, and measuring the extent of impairment could help predict mortality risk, research suggests. Dale Sandler (National Institutes of Health, Research Triangle Park, North Carolina, USA) and co-investigators say: “The evaluation …